Home Sulfonamines 73945-39-8
73945-39-8,MFCD03550609
Catalog No.:AA005VFW

73945-39-8 | Cyclopentanesulfonamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
1 week  
$187.00   $131.00
- +
250mg
95%
1 week  
$315.00   $221.00
- +
1g
95%
1 week  
$850.00   $595.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA005VFW
Chemical Name:
Cyclopentanesulfonamide
CAS Number:
73945-39-8
Molecular Formula:
C5H11NO2S
Molecular Weight:
149.2113
MDL Number:
MFCD03550609
SMILES:
NS(=O)(=O)C1CCCC1
Properties
Properties
 
Form:
Solid  
Storage:
2-8℃;  

Computed Properties
 
Complexity:
174  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
0.2  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2021/116050,2021,A1Locationinpatent:Page/Pagecolumn42

[2]CurrentPatentAssignee:UNIVERSITYOFDUBLIN;THEUNIVERSITYOFQUEENSLAND-WO2016/131098,2016,A1Locationinpatent:Page/Pagecolumn90;91

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2006/183694,2006,A1Locationinpatent:Page/Pagecolumn31

[4]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2007/10455,2007,A1Locationinpatent:Page/Pagecolumn33

[5]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/107625,2008,A1Locationinpatent:Page/Pagecolumn31

[6]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2003/99274,2003,A1Locationinpatent:Page66

[7]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2008/64061,2008,A1Locationinpatent:Page/Pagecolumn61

[8]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2007/93414,2007,A1Locationinpatent:Page/Pagecolumn44-45

[9]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2007/99825,2007,A1Locationinpatent:Page/Pagecolumn34

[10]Bravo,Yalda;Baccei,ChristopherS.;Broadhead,Alex;Bundey,Richard;Chen,Austin;Clark,Ryan;Correa,Lucia;Jacintho,JasonD.;Lorrain,DanielS.;Messmer,Davorka;Stebbins,Karin;Prasit,Peppi;Stock,Nicholas[BioorganicandMedicinalChemistryLetters,2014,vol.24,#10,p.2267-2272]

[11]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/107623,2008,A1Locationinpatent:Page/Pagecolumn30

[12]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/107624,2008,A1Locationinpatent:Page/Pagecolumn30-31

[13]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/119461,2008,A1Locationinpatent:Page/Pagecolumn29

[14]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2008/64057,2008,A1Locationinpatent:Page/Pagecolumn58-59

[15]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2022/129259,2022,A1Locationinpatent:Page/Pagecolumn54-55

[16]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2022/129259,2022,A1Locationinpatent:Page/Pagecolumn54-55

[17]CurrentPatentAssignee:ASTRAZENECAPLC-WO2022/155294,2022,A1

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/14173,2008,A1Locationinpatent:Page/Pagecolumn32

[2]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2005/51410,2005,A1Locationinpatent:Page/Pagecolumn79

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2004/48802,2004,A1

[4]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2009/274648,2009,A1

[5]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2009/304626,2009,A1

[6]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/107623,2008,A1CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/107624,2008,A1

[7]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/119461,2008,A1CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2008/64057,2008,A1

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2002/111313,2002,A1

[1]CurrentPatentAssignee:ELILILLY&CO-US5216026,1993,A

[1]CurrentPatentAssignee:ELILILLY&CO-US5216026,1993,A

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:73945-39-8 Molecular Formula|73945-39-8 MDL|73945-39-8 SMILES|73945-39-8 Cyclopentanesulfonamide